Conformis, Inc. to Release First Quarter 2022 Financial Results on May 4, 2022

Rhea-AI Summary

Conformis, Inc. (NASDAQ: CFMS) will disclose its financial results for Q1 2022 on May 4, 2022, before the market opens. A webcast will follow at 8:30 a.m. ET with CEO Mark Augusti and CFO Bob Howe discussing the results and business updates. Additionally, the company's annual stockholder meeting is scheduled for the same day at 12:00 p.m. ET. Conformis focuses on orthopedic patient care with innovative, personalized solutions for joint pain management.

BILLERICA, Mass., April 11, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today it will release its financial results for the first quarter ended March 31, 2022, before the market opens on Wednesday, May 4, 2022, at approximately 7:00 a.m. Eastern Time.

Mark Augusti, CEO, and Bob Howe, CFO, will host a webcast and conference call also on Wednesday, May 4, 2022, at 8:30 a.m. Eastern Time to discuss the financial results and to provide a business update.

The Company will hold its annual meeting of stockholders at 12:00 p.m. Eastern Time on May 4, 2022.

Earnings Call and Webcast Details:

The webcast of the earnings call will be live at: https://edge.media-server.com/mmc/p/unvfzkbo

To attend by telephone, please use the information below for dial-in access.

• Date and Time: May 4, 2022 – 8:30 a.m. Eastern Time
• When prompted on dial-in, please utilize conference ID: 905 6628
• Participant conference numbers: (877) 809-6331 (U.S./Canada) and (615) 247-0224 (International).
• Please dial in at least 10 minutes before the call to ensure timely participation.

Please visit the Investor Relations website at ir.conformis.com on May 4, 2022, to view the earnings release prior to the webcast and conference call.

The online archive of the webcast will be available on the company’s website at ir.conformis.com for 30 days.

About Conformis, Inc.

Conformis is a medical technology company focused on advancing orthopedic patient care and creating a world without joint pain. Its product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant® Platinum Services℠ Program as well as data-informed, standardized solutions that combine many benefits of personalization with the convenience and flexibility of an off-the-shelf system. Conformis’ sterile, just-in-time, Surgery-in-a-Box^™ delivery system is available with all of its implants and personalized, single-use instruments. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.

For more information, visit www.conformis.com. To receive future releases in e-mail alerts, sign up at http://ir.conformis.com/.

Contact

Investor Contact:
Investor Relations
ir@conformis.com 
(781) 374-5598

FAQ

When will Conformis release its Q1 2022 financial results?

Conformis will release its Q1 2022 financial results on May 4, 2022, before the market opens.

What time is Conformis' earnings call on May 4, 2022?

The earnings call for Conformis is scheduled for May 4, 2022, at 8:30 a.m. Eastern Time.

Where can I access the webcast for Conformis' earnings call?

The webcast for Conformis' earnings call can be accessed at their Investor Relations website or directly via the provided link in the press release.

What is the purpose of Conformis' upcoming stockholder meeting?

The stockholder meeting will provide updates regarding the company's performance and future directions.